Radiation Therapy for Cutaneous Melanoma

Dermatologic Clinics

Volumn 30, Issue 3, 2012, Pages 525-533

  Barker, Christopher A ^a   Lee, Nancy Y ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Adjuvant; Cutaneous melanoma; Desmoplastic melanoma; High risk; Lentigo maligna; Nodal recurrence; Palliation; Radiation therapy

Indexed keywords

BONE METASTASIS; BRAIN METASTASIS; CANCER CONTROL; CANCER RADIOTHERAPY; COMPARATIVE STUDY; CUTANEOUS MELANOMA; DISTANT METASTASIS; DRUG TOLERABILITY; HUMAN; LYMPH NODE METASTASIS; LYMPHEDEMA; MALIGNANT LENTIGO; MALIGNANT LENTIGO MELANOMA; PAROTITIS; PATIENT CARE; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; RETROSPECTIVE STUDY; REVIEW; SKIN METASTASIS; STEREOTACTIC RADIOSURGERY;

EVIDENCE-BASED MEDICINE; HUMANS; HUTCHINSON'S MELANOTIC FRECKLE; LYMPHATIC METASTASIS; MELANOMA; NEOPLASM RECURRENCE, LOCAL; SKIN NEOPLASMS;

EID: 84863867655     PISSN: 07338635     EISSN: 15580520     Source Type: Journal    
DOI: 10.1016/j.det.2012.04.011     Document Type: Review

References (55)

1. Delaney G., Barton M., Jacob S. Estimation of an optimal radiotherapy utilization rate for melanoma: a review of the evidence. Cancer 2004, 100(6):1293-1301.
2. French J., McGahan C., Duncan G., et al. How gender, age, and geography influence the utilization of radiation therapy in the management of malignant melanoma. Int J Radiat Oncol Biol Phys 2006, 66(4):1056-1063.
3. Williams M.V., Drinkwater K.J. Radiotherapy in England in 2007: modelled demand and audited activity. Clin Oncol (R Coll Radiol) 2009, 21(8):575-590.
4. Harwood A.R., Cummings B.J. Radiotherapy for malignant melanoma: a re-appraisal. Cancer Treat Rev 1981, 8(4):271-282.
5. Stevens G., McKay M.J. Dispelling the myths surrounding radiotherapy for treatment of cutaneous melanoma. Lancet Oncol 2006, 7(7):575-583.
6. Hawkins B.S. Collaborative Ocular Melanoma Study randomized trial of I-125 brachytherapy. Clin Trials 2011, 8(5):661-673.
7. Papadopoulos T., Rasiah K., Thompson J.F., et al. Melanoma of the nose. Br J Surg 1997, 84(7):986-989.
8. Hellriegel W. Radiation therapy of primary and metastatic melanoma. Ann N Y Acad Sci 1963, 100:131-141.
9. Mortier L., Mirabel X., Modiano P., et al. Ann Dermatol Venereol 2006, 133(2):153-156. [in French].
10. Harwood A.R. Radiotherapy of acral lentiginous melanoma of the foot. J La State Med Soc 1999, 151(7):373-376.
11. De Groot W.P. Provisional results of treatment of the mélanose précancéreuse circonscrite Dubreuilh by Bucky-rays. Dermatologica 1968, 136(5):429-431.
12. Farshad A., Burg G., Panizzon R., et al. A retrospective study of 150 patients with lentigo maligna and lentigo maligna melanoma and the efficacy of radiotherapy using Grenz or soft X-rays. Br J Dermatol 2002, 146(6):1042-1046.
13. Schmid-Wendtner M.H., Brunner B., Konz B., et al. Fractionated radiotherapy of lentigo maligna and lentigo maligna melanoma in 64 patients. J Am Acad Dermatol 2000, 43(3):477-482.
14. Kopf A.W., Bart R.S., Gladstein A.H. Treatment of melanotic freckle with x-rays. Arch Dermatol 1976, 112(6):801-807.
15. Tsang R.W., Liu F.F., Wells W., et al. Lentigo maligna of the head and neck. Results of treatment by radiotherapy. Arch Dermatol 1994, 130(8):1008-1012.
16. Lee H., Sowerby L.J., Temple C.L., et al. Carbon dioxide laser treatment for lentigo maligna: a retrospective review comparing 3 different treatment modalities. Arch Facial Plast Surg 2011, 13(6):398-403.
17. Christie D.R., Tiver K.W. Radiotherapy for melanotic freckles. Australas Radiol 1996, 40(3):331-333.
18. Cooper J.S. Patients' perceptions of their cosmetic appearance more than ten years after radiotherapy for basal cell carcinoma. Radiat Med 1988, 6(6):285-288.
19. Zalaudek I., Horn M., Richtig E., et al. Local recurrence in melanoma in situ: influence of sex, age, site of involvement and therapeutic modalities. Br J Dermatol 2003, 148(4):703-708.
20. Marsden J.R., Newton-Bishop J.A., Burrows L., et al. Revised UK guidelines for the management of cutaneous melanoma 2010. J Plast Reconstr Aesthet Surg 2010, 63(9):1401-1419.
21. Mahendran R.M., Newton-Bishop J.A. Survey of U.K. current practice in the treatment of lentigo maligna. Br J Dermatol 2001, 144(1):71-76.
22. Vongtama R., Safa A., Gallardo D., et al. Efficacy of radiation therapy in the local control of desmoplastic malignant melanoma. Head Neck 2003, 25(6):423-428.
23. Foote M.C., Burmeister B., Burmeister E., et al. Desmoplastic melanoma: the role of radiotherapy in improving local control. ANZ J Surg 2008, 78(4):273-276.
24. Chen J.Y., Hruby G., Scolyer R.A., et al. Desmoplastic neurotropic melanoma: a clinicopathologic analysis of 128 cases. Cancer 2008, 113(10):2770-2778.
25. Arora A., Lowe L., Su L., et al. Wide excision without radiation for desmoplastic melanoma. Cancer 2005, 104(7):1462-1467.
26. Feng Z., Wu X.C., Chen V., et al. Incidence and survival of desmoplastic melanoma in the United States, 1992-2007. J Cutan Pathol 2011, 38(8):616-624.
27. Wasif N., Gray R.J., Pockaj B.A. Desmoplastic melanoma-the step-child in the melanoma family?. J Surg Oncol 2011, 103(2):158-162.
28. Guadagnolo B.A., Zagars G.K. Adjuvant radiation therapy for high-risk nodal metastases from cutaneous melanoma. Lancet Oncol 2009, 10(4):409-416.
29. Creagan E.T., Cupps R.E., Ivins J.C., et al. Adjuvant radiation therapy for regional nodal metastases from malignant melanoma: a randomized, prospective study. Cancer 1978, 42(5):2206-2210.
30. Burmeister B.H., Henderson M.A., Ainslie J., et al. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relpase after therapeutic lymphadectomy for melanoma: a randomised trial. Lancet oncology 2012, 10.1016/S1470-2045(12)70138-9.
31. Burmeister B.H., Mark Smithers B., Burmeister E., et al. A prospective phase II study of adjuvant postoperative radiation therapy following nodal surgery in malignant melanoma-Trans Tasman Radiation Oncology Group (TROG) Study 96.06. Radiother Oncol 2006, 81(2):136-142.
32. Staffurth J. A review of the clinical evidence for intensity-modulated radiotherapy. Clin Oncol (R Coll Radiol) 2010, 22(8):643-657.
33. Ang K.K., Peters L.J., Weber R.S., et al. Postoperative radiotherapy for cutaneous melanoma of the head and neck region. Int J Radiat Oncol Biol Phys 1994, 30(4):795-798.
34. Suh J.H. Stereotactic radiosurgery for the management of brain metastases. N Engl J Med 2010, 362(12):1119-1127.
35. Vogelbaum M.A., Suh J.H. Resectable brain metastases. J Clin Oncol 2006, 24(8):1289-1294.
36. Roos D.E., Smith J.G., Stephens S.W. Radiosurgery versus surgery, both with adjuvant whole brain radiotherapy, for solitary brain metastases: a randomised controlled trial. Clin Oncol (R Coll Radiol) 2011, 23(9):646-651.
37. Patchell R.A., Tibbs P.A., Regine W.F., et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 1998, 280(17):1485-1489.
38. Aoyama H., Shirato H., Tago M., et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 2006, 295(21):2483-2491.
39. Chang E.L., Wefel J.S., Hess K.R., et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 2009, 10(11):1037-1044.
40. Fogarty G., Morton R.L., Vardy J., et al. Whole brain radiotherapy after local treatment of brain metastases in melanoma patients-a randomised phase III trial. BMC Cancer 2011, 11:142.
41. Manon R., O'Neill A., Knisely J., et al. Phase II trial of radiosurgery for one to three newly diagnosed brain metastases from renal cell carcinoma, melanoma, and sarcoma: an Eastern Cooperative Oncology Group study (E 6397). J Clin Oncol 2005, 23(34):8870-8876.
42. Mornex F., Thomas L., Mohr P., et al. A prospective randomized multicentre phase III trial of fotemustine plus whole brain irradiation versus fotemustine alone in cerebral metastases of malignant melanoma. Melanoma Res 2003, 13(1):97-103.
43. Carella R.J., Gelber R., Hendrickson F., et al. Value of radiation therapy in the management of patients with cerebral metastases from malignant melanoma: Radiation Therapy Oncology Group Brain Metastases Study I and II. Cancer 1980, 45(4):679-683.
44. McQuay H.J., Collins S.L., Carroll D., et al. Radiotherapy for the palliation of painful bone metastases. Cochrane Database Syst Rev 2000, (2). CD001793.
45. Huguenin P.U., Kieser S., Glanzmann C., et al. Radiotherapy for metastatic carcinomas of the kidney or melanomas: an analysis using palliative end points. Int J Radiat Oncol Biol Phys 1998, 41(2):401-405.
46. Seegenschmiedt M.H., Keilholz L., Altendorf-Hofmann A., et al. Palliative radiotherapy for recurrent and metastatic malignant melanoma: prognostic factors for tumor response and long-term outcome: a 20-year experience. Int J Radiat Oncol Biol Phys 1999, 44(3):607-618.
47. Konefal J.B., Emami B., Pilepich M.V. Analysis of dose fractionation in the palliation of metastases from malignant melanoma. Cancer 1988, 61(2):243-246.
48. Sause W.T., Cooper J.S., Rush S., et al. Fraction size in external beam radiation therapy in the treatment of melanoma. Int J Radiat Oncol Biol Phys 1991, 20(3):429-432.
49. Habermalz H.J., Fischer J.J. Radiation therapy of malignant melanoma: experience with high individual treatment doses. Cancer 1976, 38(6):2258-2262.
50. Overgaard J., von der Maase H., Overgaard M. A randomized study comparing two high-dose per fraction radiation schedules in recurrent or metastatic malignant melanoma. Int J Radiat Oncol Biol Phys 1985, 11(10):1837-1839.
51. Overgaard J., Gonzalez Gonzalez D., Hulshof M.C., et al. Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. European Society for Hyperthermic Oncology. Lancet 1995, 345(8949):540-543.
52. Gerszten P.C., Burton S.A., Quinn A.E., et al. Radiosurgery for the treatment of spinal melanoma metastases. Stereotact Funct Neurosurg 2005, 83(5-6):213-221.
53. Rusthoven K.E., Kavanagh B.D., Burri S.H., et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. J Clin Oncol 2009, 27(10):1579-1584.
54. Rusthoven K.E., Kavanagh B.D., Cardenes H., et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol 2009, 27(10):1572-1578.
55. Stinauer M.A., Kavanagh B.D., Schefter T.E., et al. Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control. Radiat Oncol 2011, 6:34.